FMR1 and neuroblastoma: Consequently, we used mouse N2A neuroblastoma cells depleted of Fmr1 by an siRNA complementary to this RNA’s 3′ UTR, which reduced FMRP levels by >95% compared to a nontargeting (NT) control (Fig 2A).